Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypersensitivity Reaction

  Free Subscription


25.10.2021

5 Allergy
1 Arch Pediatr
1 BMJ
1 Contact Dermatitis
1 Int Arch Allergy Immunol
17 J Allergy Clin Immunol
17 J Asthma
1 JAMA
1 Pediatrics
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. SOUSA-PINTO B, Anto JM, Sheikh A, de Lusignan S, et al
    Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England.
    Allergy. 2021 Oct 19. doi: 10.1111/all.15139.
    PubMed        

  2. TAGKARELI S, Salagianni M, Galani IE, Manioudaki M, et al
    CD103 integrin identifies a high IL-10-producing FoxP3(+) regulatory T cell population suppressing allergic airway inflammation.
    Allergy. 2021 Oct 17. doi: 10.1111/all.15144.
    PubMed         Abstract available

  3. GARIB V, Ben-Ali M, Kundi M, Curin M, et al
    Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper IgE syndromes.
    Allergy. 2021 Oct 15. doi: 10.1111/all.15143.
    PubMed         Abstract available

  4. LEE MF, Wu CS, Lin SJ, Chen YH, et al
    Needle-free Epicutaneous For t 2 DNA Vaccine is Effective for Preventing and Treating Biting Midge (Forcipomyia taiwana) allergy in a murine model.
    Allergy. 2021 Oct 15. doi: 10.1111/all.15141.
    PubMed        

  5. JITTHAMSTAPORN S, Sander AF, Jacquet A
    Virus-like particles displaying recombinant Der p 1 allergen to optimize IgG blocking antibody response.
    Allergy. 2021 Oct 7. doi: 10.1111/all.15129.
    PubMed        


    Arch Pediatr

  6. PONDROM M, Monpoux F, Rocher F, Gastaut N, et al
    Tolerance induction to deferasirox in a child with transfusion-dependent beta thalassemia.
    Arch Pediatr. 2021;28:101-103.
    PubMed         Abstract available


    BMJ

  7. O'CARROLL O, McCarthy C, Butler MW
    Treatments for poorly controlled asthma.
    BMJ. 2021;375:n2355.
    PubMed        


    Contact Dermatitis

  8. AHRENSBOLL-FRIIS U, Simonsen AB, Dahlin J, Isaksson M, et al
    Allergic contact dermatitis to dyes used in the temple of spectacles.
    Contact Dermatitis. 2021 Oct 15. doi: 10.1111/cod.13989.
    PubMed         Abstract available


    Int Arch Allergy Immunol

  9. SULEYMAN A, Toprak S, Guler N
    Risk Stratification as a Predictive Factor for Cephalosporin Allergy: A Case-Controlled Study.
    Int Arch Allergy Immunol. 2021 Oct 19:1-8. doi: 10.1159/000519619.
    PubMed         Abstract available


    J Allergy Clin Immunol

  10. DELGADO-ECKERT E, James A, Meier-Girard D, Kupczyk M, et al
    Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation.
    J Allergy Clin Immunol. 2021 Feb 3. pii: S0091-6749(21)00162.
    PubMed         Abstract available

  11. HSIEH LY, Chiang AWT, Duong LD, Kuo CC, et al
    A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis.
    J Allergy Clin Immunol. 2021;148:486-494.
    PubMed         Abstract available

  12. LOWE AA, Gerald JK, Clemens CJ, Stern DA, et al
    Managing respiratory emergencies at school: A county-wide stock inhaler program.
    J Allergy Clin Immunol. 2021;148:420-427.
    PubMed         Abstract available

  13. WINTER NA, Qin L, Gibson PG, Mcdonald VM, et al
    Sputum mast cell/basophil gene expression relates to inflammatory and clinical features of severe asthma.
    J Allergy Clin Immunol. 2021 Feb 18. pii: S0091-6749(21)00222.
    PubMed         Abstract available

  14. WOLF K, Kuhn H, Boehm F, Gebhardt L, et al
    A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice.
    J Allergy Clin Immunol. 2021;148:506-522.
    PubMed         Abstract available

  15. HEMMINGS O, Niazi U, Kwok M, James LK, et al
    Peanut diversity and specific activity are the dominant IgE characteristics for effector cell activation in children.
    J Allergy Clin Immunol. 2021;148:495-505.
    PubMed         Abstract available

  16. KAMIKASEDA Y, Uruno T, Kunimura K, Harada A, et al
    Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound.
    J Allergy Clin Immunol. 2021;148:633-638.
    PubMed         Abstract available

  17. BEAUFILS F, Esteves P, Enaud R, Germande O, et al
    Mitochondria are involved in bronchial smooth muscle remodeling in severe preschool wheezers.
    J Allergy Clin Immunol. 2021;148:645-651.
    PubMed         Abstract available

  18. STEVENS WW, Staudacher AG, Hulse KE, Poposki JA, et al
    Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis.
    J Allergy Clin Immunol. 2021;148:439-449.
    PubMed         Abstract available

  19. HU C, van Meel ER, Medina-Gomez C, Kraaij R, et al
    A population-based study on associations of stool microbiota with atopic diseases in school-age children.
    J Allergy Clin Immunol. 2021;148:612-620.
    PubMed         Abstract available

  20. AALBERSE RC
    Recombinant allergens need a reality check.
    J Allergy Clin Immunol. 2021 Oct 12. pii: S0091-6749(21)01522.
    PubMed        

  21. BERIN MC, Agashe C, Burks AW, Chiang D, et al
    Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
    J Allergy Clin Immunol. 2021 Oct 12. pii: S0091-6749(21)01518.
    PubMed         Abstract available

  22. EID R, Yan CH, Stevens W, Doherty TA, et al
    Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.
    J Allergy Clin Immunol. 2021;148:309-318.
    PubMed         Abstract available

  23. HAQUE R, White AA, Jackson DJ, Hopkins C, et al
    Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    J Allergy Clin Immunol. 2021;148:283-291.
    PubMed         Abstract available

  24. BUCHHEIT KM, Laidlaw TM, Levy JM
    Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease.
    J Allergy Clin Immunol. 2021;148:348-350.
    PubMed        

  25. BUCHHEIT KM, Lewis E, Gakpo D, Hacker J, et al
    Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
    J Allergy Clin Immunol. 2021;148:574-584.
    PubMed         Abstract available

  26. GRAYSON MH
    AAAAI funding opportunities.
    J Allergy Clin Immunol. 2021;148:351-354.
    PubMed        


    J Asthma

  27. DONG J, Sun D, Lu F
    Association of two polymorphisms of miRNA-146a rs2910164 (G > C) and miRNA-499 rs3746444 (T > C) with asthma: a meta-analysis.
    J Asthma. 2021;58:995-1002.
    PubMed         Abstract available

  28. AL-ABCHA A, Wang L, Reilly MJ, Rosenman KD, et al
    Work-related asthma in cobalt-exposed workers.
    J Asthma. 2021;58:1032-1041.
    PubMed         Abstract available

  29. HIRVONEN E, Karlsson A, Kilpelainen M, Lindqvist A, et al
    Development of self-assessed work ability among middle-aged asthma patients-a 10 year follow-up study.
    J Asthma. 2021;58:1042-1050.
    PubMed         Abstract available

  30. SANCHEZ-MUNOZ G, Lopez-de-Andres A, Jimenez-Garcia R, Hernandez-Barrera V, et al
    Trend from 2001 to 2015 in the prevalence of bronchiectasis among patients hospitalized for asthma and effect of bronchiectasis on the in-hospital mortality.
    J Asthma. 2021;58:1067-1076.
    PubMed         Abstract available

  31. WIREKLINT P, Hasselgren M, Montgomery S, Lisspers K, et al
    Factors associated with knowledge of self-management of worsening asthma in primary care patients: a cross-sectional study.
    J Asthma. 2021;58:1087-1093.
    PubMed         Abstract available

  32. WIDHIANINGSIH D, Koontongkaew S
    Enhancement of cariogenic virulence properties of dental plaque in asthmatics.
    J Asthma. 2021;58:1051-1057.
    PubMed         Abstract available

  33. PADE KH, Thompson LR, Ravandi B, Chang TP, et al
    Parental perception of a picture-based chronic asthma care management tool in an urban pediatric emergency department.
    J Asthma. 2021;58:1013-1023.
    PubMed         Abstract available

  34. PENNINGTON AF, Hsu J, Sircar K, Mirabelli MC, et al
    Daycare attendance and asthma control, Asthma Call-back Survey 2012-2014.
    J Asthma. 2021;58:1111-1117.
    PubMed         Abstract available

  35. BEDOLLA-BARAJAS M, Morales-Romero J, Fonseca-Lopez JC, Pulido-Guillen NA, et al
    Anxiety and depression in adult patients with asthma: the role of asthma control, obesity and allergic sensitization.
    J Asthma. 2021;58:1058-1066.
    PubMed         Abstract available

  36. SEOL HY, Wi CI, Ryu E, King KS, et al
    A diagnostic codes-based algorithm improves accuracy for identification of childhood asthma in archival data sets.
    J Asthma. 2021;58:1077-1086.
    PubMed         Abstract available

  37. ONG KY, Tan TL, Chan AKW, Tan KLL, et al
    Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: a review.
    J Asthma. 2021;58:1536-1543.
    PubMed         Abstract available

  38. NANNINI LJ, Luhning S, Rojas RA, Antunez JM, et al
    Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management?
    J Asthma. 2021;58:991-994.
    PubMed         Abstract available

  39. BLAKESTON S, Harper G, Zabala Mancebo J
    Identifying the drivers of patients' reliance on short-acting beta2-agonists in asthma.
    J Asthma. 2021;58:1094-1101.
    PubMed         Abstract available

  40. VARSANO S, Israeli L, Shitrit D
    "Severe-controlled" asthma 4 years later: is it still controlled?
    J Asthma. 2021;58:1102-1110.
    PubMed         Abstract available

  41. SINGH S, Surani S, McGuinness S, Eudicone J, et al
    Current practice patterns, challenges, and educational needs of asthma care providers in the United States.
    J Asthma. 2021;58:1118-1127.
    PubMed         Abstract available

  42. DHALIWAL C, Haji T, Leung G, Thipse M, et al
    Predictors of future acute asthma visits among children receiving guideline recommended emergency department discharge management.
    J Asthma. 2021;58:1024-1031.
    PubMed         Abstract available

  43. JIANG XH, Li CQ, Feng GY, Luo MJ, et al
    Mycobacterium vaccae nebulization protects Balb/c mice against bronchial asthma through neural mechanisms.
    J Asthma. 2021;58:1003-1012.
    PubMed         Abstract available


    JAMA

  44. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    PubMed         Abstract available


    Pediatrics

  45. DE KEYSER HH, Chipps B, Dinakar C
    Biologics for Asthma and Allergic Skin Diseases in Children.
    Pediatrics. 2021 Oct 18. pii: peds.2021-054270. doi: 10.1542/peds.2021-054270.
    PubMed         Abstract available


    PLoS One

  46. HOSKOVEC L, Benka-Coker W, Severson R, Magzamen S, et al
    Model choice for estimating the association between exposure to chemical mixtures and health outcomes: A simulation study.
    PLoS One. 2021;16:e0249236.
    PubMed         Abstract available

  47. BANTON S, Baynham A, Pezzali JG, von Massow M, et al
    Grains on the brain: A survey of dog owner purchasing habits related to grain-free dry dog foods.
    PLoS One. 2021;16:e0250806.
    PubMed         Abstract available

  48. SANDERS MGH, Nijsten T, Verlouw J, Kraaij R, et al
    Composition of cutaneous bacterial microbiome in seborrheic dermatitis patients: A cross-sectional study.
    PLoS One. 2021;16:e0251136.
    PubMed         Abstract available

  49. OZKAN M, Eskiocak YC, Wingender G
    Macrophage and dendritic cell subset composition can distinguish endotypes in adjuvant-induced asthma mouse models.
    PLoS One. 2021;16:e0250533.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  50. VOISIN T, Perner C, Messou MA, Shiers S, et al
    The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: